Head-to-head · Value Score
CoreAge Rx vs SexyMD
Two GLP-1 deals, scored on the same six factors. CoreAge Rx lands a Value Score of 93, SexyMD a 63. Here's who gives you the honest lower price — and where each one bites back.
CoreAge Rx
#1 · Grade A+ · Best Value
Est. first month
$99/mo
Save ~89% vs brand-nameSexyMD
#347 · Grade C · Watch List
Est. first month
$269/mo month-to-month on the four-week plan (every headline on the site quotes $199, which is the 48-week commitment rate)
Save ~80% vs brand-nameThe verdict
CoreAge Rx takes it on Value Score, 93 to 63 — an est. $99/mo first month, with no teaser step-up baked in. SexyMD isn't out of it: Shoppers who will read the four-week column of the price table rather than the headline, and who want the state exclusions named before starting.
CoreAge Rx is also our overall #1 pick across the whole deals ranking — a flat, all-in price on both molecules in all 50 states. That's why it wins here on the score, not just this matchup.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | CoreAge Rx | SexyMD |
|---|---|---|
| Value Score | 93 (A+) | 63 (C) |
| Est. first month | $99/mo | $269/mo month-to-month on the four-week plan (every headline on the site quotes $199, which is the 48-week commitment rate) |
| Save vs brand-name | ~89% | ~80% |
| Semaglutide | $99/mo | $269/mo month-to-month on the four-week plan (every headline on the site quotes $199, which is the 48-week commitment rate) |
| Tirzepatide | $149/mo | $369/mo month-to-month on the four-week plan (the $299 headline is the 48-week rate) |
| Both molecules | Yes | Yes |
| Pricing | Flat — no step-up | Watch |
| Coverage | All 50 states | 47 states — not Arkansas, Mississippi or New Jersey |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
CoreAge Rx
The honest lowest price: both molecules at one flat, all-in monthly rate that never steps up after month one.
Why it's a deal
- Flat, all-in monthly price with no intro-rate step-ups after month one
- Both compounded semaglutide and tirzepatide on one account
- Available in all 50 states
- Straightforward, low-friction cancellation — no lock-in
The fine print
- Not the rock-bottom sticker — a couple of teaser tiers advertise lower month-one rates
- No FDA-approved brand-name option (compounded only)
- Does not yet publicly name its 503A/B pharmacy partner
SexyMD
Compounded semaglutide at $269 a month and tirzepatide at $369, headlined everywhere on the site as $199 and $299 — the rates for committing to forty-eight weeks.
Why it's a deal
- The whole ladder is published on the product pages before any intake: $269, $249, $229 and $199 for semaglutide across four, twelve, twenty-four and forty-eight weeks, and $369, $349, $329 and $299 for tirzepatide
- The exclusions are named. One line in the footer says the service is available in all states except three, listed by name — which is the useful half of the coverage statement
- Both pharmacy classes are disclosed in the terms, 503A pharmacies and 503B outsourcing facilities, with what each is regulated by
- A medical practice and a named physician stand behind the prescribing, identified in the terms rather than described as a category
- Cancellation is through the account dashboard or by contacting support, forty-eight hours before the next renewal, and the mechanism is stated once
- Two low-dose products are sold at published prices rather than hidden behind an eligibility check
The fine print
- Every headline on the site is the forty-eight-week rate. "From $199 per month" is what a buyer pays after committing to nearly a year; the month-to-month rate is $269, a difference of $840 over a year
- The asterisk attached to that headline resolves to no footnote anywhere on the page
- The same footer block, on every page of the site, says both that the service is available in all fifty states and that it is available in all states except three. Both sentences are printed together
- The twenty-four- and forty-eight-week tiers print a per-month price while shipping quarterly, and the terms defer the actual charge amount and cadence to the checkout — so whether it is one charge, four or twelve is unpublished
- The two low-dose products price four, eight and twelve weeks identically, in the same table format that carries real tiers on the full-dose pages, so a plan-length table appears where no plan-length discount exists
- Three social-proof figures disagree with each other across the site, and the checkout claims two patient counts for a single day that together exceed the site's own badge by more than thirty times
- A scarcity countdown at the checkout reads that only one discount is left and reserves it for twenty-five minutes, resetting for each new session
- One low-dose page contradicts itself on dosing frequency in its own body copy against its own instructions
- The only phone number on the site is a vanity string in the terms with no digits given, and no pharmacy is named
- What the price includes is never itemized: consultation, shipping, supplies and dose escalation appear on no product page
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores CoreAge Rx is ranked on the CoreAge Rx alternatives ranking, and the same list for the other side is on alternatives to SexyMD.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.